Redmond JL, Kendall F, Smith NMJ, Magor-Elliott SRM, Hallifax RJ, Fullerton CJ, Richmond G, Couper JH, Ritchie GAD, Robbins PA, Petousi N, and Talbot NP
Competing Interests: Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: Oxford University Innovation, a wholly owned subsidiary of the University of Oxford, holds/has filed patents relating to the background IP for the technology used in this work. P. A. R., G. A. D. R., and J. H. C. have an interest in one or more of these patents. J. L. R. has received support from the EPSRC, UKRI, and Eurofins Foundation. N. M. J. S. has received support from the EPSRC. S. R. M. M. has received support from the British Heart Foundation. C. J. F. has received support from the NIHR Oxford Biomedical Research Centre (BRC). G. A. D. R. has received research funding from the EPSRC. P. A. R has received research funding from the NIHR Oxford BRC. N. P. has received support from the NIHR Oxford BRC and speaker fees from AstraZeneca. None declared (F. K., R. J. H., G. R., and N. P. T.).